🇺🇸 FDA
Patent

US 7622113

Monoclonal antibodies that bind or neutralize dengue virus

granted A61KA61K2039/505A61P

Quick answer

US patent 7622113 (Monoclonal antibodies that bind or neutralize dengue virus) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K2039/505, A61P, A61P31/12